AUG 20, 2014 07:15 AM PDT

Establishing cell-free biology for the production of therapeutics, materials, and chemicals

Speakers
  • Assistant Professor of Chemical and Biological Engineering, Northwestern University
    Biography
      Michael Jewett is an Assistant Professor of Chemical and Biological Engineering and Member of the Chemistry of Life Processes Institute at Northwestern University. He received his PhD in 2005 at Stanford University.  After completing postdoctoral studies as an NSF International Research Fellow at the Center for Microbial Biotechnology in Denmark and as an NIH Pathway to Independence Fellow at the Harvard Medical School, he joined Northwestern in 2009.  Mike is developing cell-free biology as an enabling technology for biomanufacturing lifesaving therapeutics, sustainable chemicals, and novel materials, both quickly and on-demand. He focuses on designing, constructing, and modifying biological systems involved in protein synthesis and metabolism, with promise to advance new paradigms for synthetic biology. In 2011, he was honored with a David and Lucile Packard Fellowship in Science and Engineering, the DARPA Young Faculty Award, and the Agilent Early Career Professor Award.

    Abstract:

    Imagine a world in which we could adapt biology to manufacture any therapeutic, material, or chemical from renewable resources, both quickly and on demand. Industrial biotechnology is one of the most attractive approaches for addressing this need, particularly when large-scale chemical synthesis is untenable. Unfortunately, the fraction of biobased products amenable to economical production is limited because engineering whole-cell microorganisms with synthetic pathways remains costly and slow. We hypothesize that a key problem to these efforts lies with the inherent limitations imposed by cells. Microbial cells exist to produce more cells, not to produce items of commerce, which often are an unnecessary or even toxic burden on the primary cellular objectives of growth and adaptation. This leads to a variety of challenges afflicting the current state-of-the-art, including: low yields and productivities, build-up of toxic intermediates or products, and byproduct losses via competing pathways. To overcome these limitations, we are expanding the scope of the traditional engineering model in biotechnology by using cell-free systems to harness ensembles of catalytic proteins prepared from crude lysates, or extracts, of cells for the production of target products. Rather than attempt to balance the tug-of-war between the cells objectives and the engineers objectives, we are developing new paradigms for designing, building, and testing cell-free systems that harness and modify biological systems involved in protein synthesis and metabolism. In this presentation, I will discuss our efforts to develop cost-effective, high-throughput cell-free protein synthesis platforms, expand the chemistry of life using non canonical amino acids, construct and evolve synthetic ribosomes, and produce sustainable chemicals with ultrahigh productivities. Our work is enabling a deeper understanding of why natures designs work the way they do and opening new frontiers for biomanufacturing.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 29, 2018 09:00 AM PDT
    C.E. CREDITS
    JUN 29, 2018 09:00 AM PDT
    DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
    Loading Comments...